ELIZABETH E REED Insider Trading $RTRX Travere Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ELIZABETH E REED.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ELIZABETH E REED. ELIZABETH E REED is SVP, GC & Corporate Secretary in Retrophin, Inc. ($RTRX).

ELIZABETH E REED in Travere Therapeutics, Inc.

Trading Symbol: RTRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ELIZABETH E REED: SVP, GC & Corporate Secretary
Holdings: 42,205 shares
Current Value: $847,054
Latest Transaction: Feb 05 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ELIZABETH E REED in Travere Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 05 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...GrantA0.004,500042,20537.7 K to 42.2 K (+11.93 %)
Feb 05 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...GrantA0.004,500042,20537.7 K to 42.2 K (+11.93 %)
Feb 03 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...SellS28.9167519,51437,70538.4 K to 37.7 K (-1.76 %)
Feb 03 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...SellS28.912,50072,27538,38040.9 K to 38.4 K (-6.12 %)
Feb 02 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...SellS30.7567520,75640,88041.6 K to 40.9 K (-1.62 %)
Feb 02 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...SellS30.752,50076,87541,55544.1 K to 41.6 K (-5.67 %)
Feb 02 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...GrantA0.005,000044,05539.1 K to 44.1 K (+12.80 %)
Jan 25 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA26.8857,5001,545,60057,500
Jan 25 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...GrantA0.0015,000039,05524.1 K to 39.1 K (+62.36 %)
Jan 07 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...SellS27.0168818,58324,05524.7 K to 24.1 K (-2.78 %)
Jan 07 2021RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...SellS26.6568818,33524,74325.4 K to 24.7 K (-2.71 %)
Nov 17 2020RTRXTravere Therapeuti ...REED ELIZABETH ESVP, GC & Corporate ...SellS23.982,50059,95025,43127.9 K to 25.4 K (-8.95 %)
Nov 13 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS23.622,50059,04627,93130.4 K to 27.9 K (-8.22 %)
Nov 13 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.005,000030,43125.4 K to 30.4 K (+19.66 %)
Sep 23 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS18.481,50027,72025,43126.9 K to 25.4 K (-5.57 %)
Sep 22 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS18.591,50027,88526,93128.4 K to 26.9 K (-5.28 %)
Sep 22 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.003,000028,43125.4 K to 28.4 K (+11.80 %)
Sep 22 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS18.591,50027,88526,93128.4 K to 26.9 K (-5.28 %)
Sep 22 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.003,000028,43125.4 K to 28.4 K (+11.80 %)
May 13 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS16.985278,95125,43126 K to 25.4 K (-2.03 %)
May 13 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS17.165259,00925,95826.5 K to 26 K (-1.98 %)
May 13 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS14.955257,84926,48327 K to 26.5 K (-1.94 %)
May 13 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS16.985278,95125,43126 K to 25.4 K (-2.03 %)
May 13 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS17.165259,00925,95826.5 K to 26 K (-1.98 %)
May 13 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS14.955257,84926,48327 K to 26.5 K (-1.94 %)
Mar 12 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS15.023,50052,57027,00830.5 K to 27 K (-11.47 %)
Mar 09 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.003,500030,50827 K to 30.5 K (+12.96 %)
Jan 31 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA0.0010,000010,000
Jan 31 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA0.009,00009,000
Jan 31 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA15.4655,000850,30055,000
Jan 31 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.009,000027,00818 K to 27 K (+49.98 %)
Jan 08 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS15.1475011,35518,00818.8 K to 18 K (-4.00 %)
Jan 08 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS13.9475010,45518,75819.5 K to 18.8 K (-3.84 %)
Jan 08 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS15.1475011,35518,00818.8 K to 18 K (-4.00 %)
Jan 08 2020RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS13.9475010,45518,75819.5 K to 18.8 K (-3.84 %)
May 16 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS17.715259,29819,50820 K to 19.5 K (-2.62 %)
May 16 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS17.755259,31920,03320.6 K to 20 K (-2.55 %)
May 10 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA0.006,00006,000
May 10 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA0.006,00006,000
May 10 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA17.9640,000718,40040,000
May 10 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA17.9640,000718,40040,000
May 10 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.006,000020,55814.6 K to 20.6 K (+41.21 %)
May 10 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.006,000020,55814.6 K to 20.6 K (+41.21 %)
Feb 13 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS21.5088419,00614,55815.4 K to 14.6 K (-5.72 %)
Feb 13 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS21.3888518,92115,44216.3 K to 15.4 K (-5.42 %)
Jan 09 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS23.8275017,86516,32717.1 K to 16.3 K (-4.39 %)
Jan 09 2019RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS24.0975018,06817,07717.8 K to 17.1 K (-4.21 %)
Nov 16 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS24.811002,48117,82717.9 K to 17.8 K (-0.56 %)
Nov 16 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS24.771002,47717,92718 K to 17.9 K (-0.55 %)
Nov 16 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS24.292,30055,85818,02720.3 K to 18 K (-11.31 %)
Nov 16 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS24.573007,37120,32720.6 K to 20.3 K (-1.45 %)
Nov 16 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS23.622,20051,95920,62722.8 K to 20.6 K (-9.64 %)
May 14 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA0.007,00007,000
May 14 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA25.2542,0001,060,50042,000
May 14 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.007,000017,82710.8 K to 17.8 K (+64.65 %)
Feb 12 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.001,769010,8279.1 K to 10.8 K (+19.53 %)
Jan 08 2018RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...SellS24.0494222,6469,05810 K to 9.1 K (-9.42 %)
Jan 06 2017RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...Option ExerciseA19.0850,000954,00050,000
Jan 06 2017RTRXRetrophin, Inc.REED ELIZABETH ESVP, GC & Corporate ...GrantA0.0010,000010,0000 to 10 K

Page:   1

Contact us | Follow us on Twitter